Cargando…
Pulmonary Fibrosis in the Time of COVID-19
Autores principales: | Buendia-Roldan, Ivette, Valenzuela, Claudia, Selman, Moisés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SEPAR. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012509/ https://www.ncbi.nlm.nih.gov/pubmed/35491285 http://dx.doi.org/10.1016/j.arbres.2022.03.007 |
Ejemplares similares
-
Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis
por: Maldonado, Mariel, et al.
Publicado: (2018) -
Immunoglobulin Free Light Chains Are Increased in Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
por: Groot Kormelink, Tom, et al.
Publicado: (2011) -
Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis
por: Buendía-Roldán, Ivette, et al.
Publicado: (2016) -
Mortality in patients with interstitial lung diseases hospitalized by severe or critical COVID-19
por: Pruneda, Ana Karem S., et al.
Publicado: (2023) -
Fibroblasts From Idiopathic Pulmonary Fibrosis Induce Apoptosis and Reduce the Migration Capacity of T Lymphocytes
por: Chavez-Galan, Leslie, et al.
Publicado: (2022)